Trial intelligence / Profile preview

Doripenem vs meropenem in complicated urinary tract infection

CTR20130289Phase 3Suspended

Sponsor
Shandong New Era Pharmaceutical
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of doripenem in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Shandong New Era Pharmaceutical. Started Apr 2015; status: suspended.

02

Drugs

doripenem
03

Conditions

complicated urinary tract infection (cUTI)pyelonephritis

Beyond the preview

Go deeper on CTR20130289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call